Zobrazeno 1 - 10 of 1 176 pro vyhledávání: '"Onorato, J"'
2
Akademický článek
DGKα/ζ inhibitors combine with PD-1 checkpoint therapy to promote T cell-mediated antitumor immunity.
Autor: Wichroski M; Research and Development, Bristol Myers Squibb Company, Cambridge, MA 02142, USA., Benci J; Research and Development, Bristol Myers Squibb Company, Lawrenceville, NJ 08648, USA., Liu SQ; Research and Development, Bristol Myers Squibb Company, Cambridge, MA 02142, USA., Chupak L; Research and Development, Bristol Myers Squibb Company, Cambridge, MA 02142, USA., Fang J; Research and Development, Bristol Myers Squibb Company, Lawrenceville, NJ 08648, USA., Cao C; Research and Development, Bristol Myers Squibb Company, Lawrenceville, NJ 08648, USA., Wang C; Research and Development, Bristol Myers Squibb Company, Lawrenceville, NJ 08648, USA., Onorato J; Research and Development, Bristol Myers Squibb Company, Lawrenceville, NJ 08648, USA., Qiu H; Research and Development, Bristol Myers Squibb Company, Cambridge, MA 02142, USA., Shan Y; Research and Development, Bristol Myers Squibb Company, Cambridge, MA 02142, USA., Banas D; Research and Development, Bristol Myers Squibb Company, Lawrenceville, NJ 08648, USA., Powles R; Research and Development, Bristol Myers Squibb Company, Cambridge, MA 02142, USA., Locke G; Research and Development, Bristol Myers Squibb Company, Lawrenceville, NJ 08648, USA., Witt A; Research and Development, Bristol Myers Squibb Company, Cambridge, MA 02142, USA., Stromko C; Research and Development, Bristol Myers Squibb Company, Lawrenceville, NJ 08648, USA., Qi H; Research and Development, Bristol Myers Squibb Company, Cambridge, MA 02142, USA., Zheng X; Research and Development, Bristol Myers Squibb Company, Cambridge, MA 02142, USA., Martin S; Research and Development, Bristol Myers Squibb Company, Cambridge, MA 02142, USA., Ding M; Research and Development, Bristol Myers Squibb Company, Cambridge, MA 02142, USA., Gentles R; Research and Development, Bristol Myers Squibb Company, Cambridge, MA 02142, USA., Meanwell N; Research and Development, Bristol Myers Squibb Company, Lawrenceville, NJ 08648, USA., Velaparthi U; Research and Development, Bristol Myers Squibb Company, Lawrenceville, NJ 08648, USA., Olson R; Research and Development, Bristol Myers Squibb Company, Cambridge, MA 02142, USA., Wee S; Research and Development, Bristol Myers Squibb Company, Lawrenceville, NJ 08648, USA., Tenney D; Research and Development, Bristol Myers Squibb Company, Lawrenceville, NJ 08648, USA., Parker CG; Department of Chemistry, Scripps Research Institute, La Jolla, CA 92037, USA., Cravatt BF; Department of Chemistry, Scripps Research Institute, La Jolla, CA 92037, USA., Lawrence M; Research and Development, Bristol Myers Squibb Company, Lawrenceville, NJ 08648, USA., Borzilleri R; Research and Development, Bristol Myers Squibb Company, Lawrenceville, NJ 08648, USA., Lees E; Research and Development, Bristol Myers Squibb Company, Cambridge, MA 02142, USA.
Publikováno v: Science translational medicine [Sci Transl Med] 2023 Oct 25; Vol. 15 (719), pp. eadh1892. Date of Electronic Publication: 2023 Oct 25.
Zobrazit plný text záznamu
3
Akademický článek
Apixaban Use in Obese Patients: A Review of the Pharmacokinetic, Interventional, and Observational Study Data.
Autor: Jamieson MJ; Internal Medicine, Medical affairs, Pfizer, New York, NY, 10017, USA. jamiem@pfizer.com., Byon W; Global Product Development, Clinical Pharmacology, Pfizer, Groton, CT, 06340, USA., Dettloff RW; Internal Medicine, Medical affairs, Pfizer, New York, NY, 10017, USA., Crawford M; Worldwide Research and Development, Computational Sciences, Pfizer, New York, NY, 10017, USA., Gargalovic PS; US Medical Cardiovascular, Bristol Myers Squibb, Princeton, NJ, 08648, USA., Merali SJ; Clinical Pharmacology and Pharmacometrics, Bristol Myers Squibb, Princeton, NJ, 08648, USA., Onorato J; US Medical Cardiovascular, Bristol Myers Squibb, Princeton, NJ, 08648, USA., Quintero AJ; Internal Medicine, Medical Affairs, Medical Innovation and Effectiveness, Pfizer, New York, NY, 10017, USA., Russ C; Internal Medicine, Medical affairs, Pfizer, New York, NY, 10017, USA.
Publikováno v: American journal of cardiovascular drugs : drugs, devices, and other interventions [Am J Cardiovasc Drugs] 2022 Nov; Vol. 22 (6), pp. 615-631. Date of Electronic Publication: 2022 May 16.
Zobrazit plný text záznamu
4
Akademický článek
Diacylglycerol Kinases and Its Role in Lipid Metabolism and Related Diseases.
Autor: Liu, Yishi1 (AUTHOR) liuyishi@jiangnan.edu.cn, Yang, Zehui1 (AUTHOR), Zhou, Xiaoman1 (AUTHOR), Li, Zijie1 (AUTHOR), Hideki, Nakanishi1 (AUTHOR)
Publikováno v: International Journal of Molecular Sciences. Dec2024, Vol. 25 Issue 23, p13207. 17p.
Zobrazit plný text záznamu
5
Akademický článek
In Vitro and In Vivo Evaluation of a Small-Molecule APJ (Apelin Receptor) Agonist, BMS-986224, as a Potential Treatment for Heart Failure.
Autor: Gargalovic P; Bristol Myers Squibb, Drug Discovery, Princeton, NJ (P.G., P.W., J.O., H.F., T.W., M.Y., E.C., C.X., X.-Q.C., C.G., M.L., R.W., D.G.)., Wong P; Bristol Myers Squibb, Drug Discovery, Princeton, NJ (P.G., P.W., J.O., H.F., T.W., M.Y., E.C., C.X., X.-Q.C., C.G., M.L., R.W., D.G.)., Onorato J; Bristol Myers Squibb, Drug Discovery, Princeton, NJ (P.G., P.W., J.O., H.F., T.W., M.Y., E.C., C.X., X.-Q.C., C.G., M.L., R.W., D.G.)., Finlay H; Bristol Myers Squibb, Drug Discovery, Princeton, NJ (P.G., P.W., J.O., H.F., T.W., M.Y., E.C., C.X., X.-Q.C., C.G., M.L., R.W., D.G.)., Wang T; Bristol Myers Squibb, Drug Discovery, Princeton, NJ (P.G., P.W., J.O., H.F., T.W., M.Y., E.C., C.X., X.-Q.C., C.G., M.L., R.W., D.G.)., Yan M; Bristol Myers Squibb, Drug Discovery, Princeton, NJ (P.G., P.W., J.O., H.F., T.W., M.Y., E.C., C.X., X.-Q.C., C.G., M.L., R.W., D.G.)., Crain E; Bristol Myers Squibb, Drug Discovery, Princeton, NJ (P.G., P.W., J.O., H.F., T.W., M.Y., E.C., C.X., X.-Q.C., C.G., M.L., R.W., D.G.)., St-Onge S; Universite de Montreal, Drug Discovery Unit at Institute for Research in Immunology and Cancer (S.S.-O., M.H., M.B.)., Héroux M; Universite de Montreal, Drug Discovery Unit at Institute for Research in Immunology and Cancer (S.S.-O., M.H., M.B.)., Bouvier M; Universite de Montreal, Drug Discovery Unit at Institute for Research in Immunology and Cancer (S.S.-O., M.H., M.B.).; Department of Biochemistry and Molecular Medicine, Université de Montréal, QC, Canada (M.B.)., Xu C; Bristol Myers Squibb, Drug Discovery, Princeton, NJ (P.G., P.W., J.O., H.F., T.W., M.Y., E.C., C.X., X.-Q.C., C.G., M.L., R.W., D.G.)., Chen XQ; Bristol Myers Squibb, Drug Discovery, Princeton, NJ (P.G., P.W., J.O., H.F., T.W., M.Y., E.C., C.X., X.-Q.C., C.G., M.L., R.W., D.G.)., Generaux C; Bristol Myers Squibb, Drug Discovery, Princeton, NJ (P.G., P.W., J.O., H.F., T.W., M.Y., E.C., C.X., X.-Q.C., C.G., M.L., R.W., D.G.)., Lawrence M; Bristol Myers Squibb, Drug Discovery, Princeton, NJ (P.G., P.W., J.O., H.F., T.W., M.Y., E.C., C.X., X.-Q.C., C.G., M.L., R.W., D.G.)., Wexler R; Bristol Myers Squibb, Drug Discovery, Princeton, NJ (P.G., P.W., J.O., H.F., T.W., M.Y., E.C., C.X., X.-Q.C., C.G., M.L., R.W., D.G.)., Gordon D; Bristol Myers Squibb, Drug Discovery, Princeton, NJ (P.G., P.W., J.O., H.F., T.W., M.Y., E.C., C.X., X.-Q.C., C.G., M.L., R.W., D.G.).
Publikováno v: Circulation. Heart failure [Circ Heart Fail] 2021 Mar; Vol. 14 (3), pp. e007351. Date of Electronic Publication: 2021 Mar 05.
Zobrazit plný text záznamu
6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
7
Akademický článek
Qualified method for the estimation of di-18:1 bis(monoacylglycero)phosphate in urine, a noninvasive biomarker to monitor drug-induced phospholipidosis.
Autor: Murali BV; Pharmaceutical Candidate Optimization, Biocon Bristol Myers Squibb R&D Center (BBRC), Syngene International Limited, Biocon Park, Plot 2 & 3, Bommasandra IV Phase, Bangalore 560099, India., Kurawattimath V; Pharmaceutical Candidate Optimization, Biocon Bristol Myers Squibb R&D Center (BBRC), Syngene International Limited, Biocon Park, Plot 2 & 3, Bommasandra IV Phase, Bangalore 560099, India., Bhutani P; Pharmaceutical Candidate Optimization, Biocon Bristol Myers Squibb R&D Center (BBRC), Syngene International Limited, Biocon Park, Plot 2 & 3, Bommasandra IV Phase, Bangalore 560099, India., Onorato J; Bristol Myers Squibb, Princeton, NJ 08648, USA., Naikodi SB; Pharmaceutical Candidate Optimization, Biocon Bristol Myers Squibb R&D Center (BBRC), Syngene International Limited, Biocon Park, Plot 2 & 3, Bommasandra IV Phase, Bangalore 560099, India., Kole P; Pharmaceutical Candidate Optimization, Biocon Bristol Myers Squibb R&D Center (BBRC), Syngene International Limited, Biocon Park, Plot 2 & 3, Bommasandra IV Phase, Bangalore 560099, India., Rajanna PK; Pharmaceutical Candidate Optimization, Biocon Bristol Myers Squibb R&D Center (BBRC), Syngene International Limited, Biocon Park, Plot 2 & 3, Bommasandra IV Phase, Bangalore 560099, India.
Publikováno v: Bioanalysis [Bioanalysis] 2020 Aug; Vol. 12 (15), pp. 1049-1059. Date of Electronic Publication: 2020 Jul 31.
Zobrazit plný text záznamu
8
Akademický článek
Ferroptosis—A Shared Mechanism for Parkinson's Disease and Type 2 Diabetes.
Autor: Duță, Carmen1 (AUTHOR) carmen.duta@umfcd.ro, Muscurel, Corina1 (AUTHOR), Dogaru, Carmen Beatrice1 (AUTHOR) corina.muscurel@umfcd.ro, Stoian, Irina1 (AUTHOR)
Publikováno v: International Journal of Molecular Sciences. Aug2024, Vol. 25 Issue 16, p8838. 34p.
Zobrazit plný text záznamu
9
Akademický článek
Physiological Biomarkers of Upper Motor Neuron Dysfunction in ALS.
Autor: Calma, Aicee Dawn1 (AUTHOR) csantosilva2@gmail.com, van den Bos, Mehdi1 (AUTHOR), Pavey, Nathan1 (AUTHOR), Santos Silva, Cláudia1,2,3 (AUTHOR), Menon, Parvathi1 (AUTHOR), Vucic, Steve1 (AUTHOR) steve.vucic@sydney.edu.au
Publikováno v: Brain Sciences (2076-3425). Aug2024, Vol. 14 Issue 8, p760. 19p.
Zobrazit plný text záznamu
10
Akademický článek
Biphenyl Acid Derivatives as APJ Receptor Agonists.
Autor: Su S; Research and Development , Bristol-Myers Squibb, Co. , P.O. Box 5400, Princeton , New Jersey 08543-5400 , United States., Clarke A; Research and Development , Bristol-Myers Squibb, Co. , P.O. Box 5400, Princeton , New Jersey 08543-5400 , United States., Han Y; Research and Development , Bristol-Myers Squibb, Co. , P.O. Box 5400, Princeton , New Jersey 08543-5400 , United States., Chao HJ; Research and Development , Bristol-Myers Squibb, Co. , P.O. Box 5400, Princeton , New Jersey 08543-5400 , United States., Bostwick J; Research and Development , Bristol-Myers Squibb, Co. , P.O. Box 5400, Princeton , New Jersey 08543-5400 , United States., Schumacher W; Research and Development , Bristol-Myers Squibb, Co. , P.O. Box 5400, Princeton , New Jersey 08543-5400 , United States., Wang T; Research and Development , Bristol-Myers Squibb, Co. , P.O. Box 5400, Princeton , New Jersey 08543-5400 , United States., Yan M; Research and Development , Bristol-Myers Squibb, Co. , P.O. Box 5400, Princeton , New Jersey 08543-5400 , United States., Hsu MY; Research and Development , Bristol-Myers Squibb, Co. , P.O. Box 5400, Princeton , New Jersey 08543-5400 , United States., Simmons E; Research and Development , Bristol-Myers Squibb, Co. , P.O. Box 5400, Princeton , New Jersey 08543-5400 , United States., Luk C; Research and Development , Bristol-Myers Squibb, Co. , P.O. Box 5400, Princeton , New Jersey 08543-5400 , United States., Xu C; Research and Development , Bristol-Myers Squibb, Co. , P.O. Box 5400, Princeton , New Jersey 08543-5400 , United States., Dabros M; Research and Development , Bristol-Myers Squibb, Co. , P.O. Box 5400, Princeton , New Jersey 08543-5400 , United States., Galella M; Research and Development , Bristol-Myers Squibb, Co. , P.O. Box 5400, Princeton , New Jersey 08543-5400 , United States., Onorato J; Research and Development , Bristol-Myers Squibb, Co. , P.O. Box 5400, Princeton , New Jersey 08543-5400 , United States., Gordon D; Research and Development , Bristol-Myers Squibb, Co. , P.O. Box 5400, Princeton , New Jersey 08543-5400 , United States., Wexler R; Research and Development , Bristol-Myers Squibb, Co. , P.O. Box 5400, Princeton , New Jersey 08543-5400 , United States., Gargalovic PS; Research and Development , Bristol-Myers Squibb, Co. , P.O. Box 5400, Princeton , New Jersey 08543-5400 , United States., Lawrence RM; Research and Development , Bristol-Myers Squibb, Co. , P.O. Box 5400, Princeton , New Jersey 08543-5400 , United States.
Publikováno v: Journal of medicinal chemistry [J Med Chem] 2019 Nov 27; Vol. 62 (22), pp. 10456-10465. Date of Electronic Publication: 2019 Nov 14.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje